Pilot study of Hycamtin in combination with Cisplati
Phase 1
- Conditions
- Small cell lung cancer
- Registration Number
- JPRN-jRCT2080220961
- Lead Sponsor
- ippon Kayaku Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) Histological or cytological diagnosis of SCLC
2) Measurable disease
3) Adequate organ function
4) ECOG Performance Status 0-1
5) Life expectancy at least 3 months
6) Written informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method